See how these capabilities enhance the speed, quality & extent of metabolite identification for accelerated insights.
See how these capabilities enhance the speed, quality & extent of metabolite identification for accelerated insights.
How next-gen proteomics methods for protein biomarker discovery are opening exciting new avenues in CDx development.
Now available on demand! See the scientific innovations expanding the druggable space and enabling discovery of novel targets.
Talking multiomics data and how it can take pharmacogenomics to the next level such as in predicting patient response.
Featuring Sapient’s platform as an omics technology advancing the discovery & implementation of dynamic biomarkers.
How multi-omics biomarker strategies are helping to realize the incredible therapeutic potential in these pipelines today.
Dr. Usuka will lead global business strategy for commercial collaborations, strategic partnerships & client service innovations.
Explore how our /Deep/ Cell Surface Proteomics method is optimized to accelerate development of T cell engagers.
See how our method is optimized to measure cancer cell surface receptors at unprecedented depth and scale.
PharmaShots profiles Sapient’s high throughput proteomics and how our services fulfill market gaps for drug development.
